Cognitive Therapy for PTSD in Addiction Treatment
1 other identifier
interventional
49
1 country
3
Brief Summary
The purpose of this phase of the study is to assess the feasibility of a cognitive behavioral therapy for post-traumatic stress disorder (PTSD) in persons receiving outpatient services at an addiction treatment program. The next phase of the study will be a more rigorous investigation of the efficacy of the PTSD therapy within addiction treatment settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Nov 2004
Typical duration for phase_1
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2006
CompletedFirst Submitted
Initial submission to the registry
May 23, 2008
CompletedFirst Posted
Study publicly available on registry
May 28, 2008
CompletedSeptember 29, 2011
September 1, 2011
1.7 years
May 23, 2008
September 28, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
decrease in substance use at post-therapy and 3 month follow-up
reduction in PTSD symptoms at post-therapy and 3 month follow-up
improvement in addiction treatment retention
Secondary Outcomes (4)
examine impact of depression, anxiety, and borderline personality disorder on outcomes
explore impact of motivation and treatment readiness on outcomes
assess overall level of satisfaction with treatment on outcomes
examine impact of other services received on outcomes
Interventions
Eligibility Criteria
You may qualify if:
- At least 18 years old;
- Actively enrolled in intensive outpatient addiction services;
- Diagnosis of PTSD; and
- Willing and able to provide informed consent.
You may not qualify if:
- Acute psychotic disorder;
- Psychiatric hospitalization or suicide attempt in the past 2 months;
- Known impending court appearance or legal circumstance that may result in incarceration within next 8 months; and
- Known medical condition that would likely cause study withdrawal in the next 8 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Fresh Start at Concord Hospital
Concord, New Hampshire, 03301, United States
Farnum Center
Manchester, New Hampshire, 03104, United States
Quitting Time
Wilder, Vermont, 05088, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark P. McGovern, Ph.D.
Dartmouth-Hitchcock Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 23, 2008
First Posted
May 28, 2008
Study Start
November 1, 2004
Primary Completion
August 1, 2006
Study Completion
November 1, 2006
Last Updated
September 29, 2011
Record last verified: 2011-09